Edwards Lifesciences Corp. said that its board has authorized a program to repurchase up to an additional $750 million worth of the company’s stock, Dow Jones reported. The company has a market capitalization value of $7.6 billion, according to FactSet. Separately Tuesday, the company said chief financial officer Thomas M. Abate will retire this year; he turns 60 in August. Edwards is the biggest maker of aortic heart valves implanted with a catheter.
Edwards Lifesciences to buy back shares
May 15, 2013
Read it all, now.
Don't miss any of your favorite stories again. Read the stories that matter to you as much as you want, whenever you want when you subscribe to BostonGlobe.com.
Get full access today for just 99¢